FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to methods for improving male reproductive function, and can be used to increase sperm cell viability and activity. Inhalation exposure is carried out with a mixture consisting of the following gases, wt.%: argon – 65-75%, oxygen – 25-35%. Duration of inhalation session is 10 to 120 minutes, course is up to 10 sessions.
EFFECT: method enables achieving high activity and viability of sperm cells by using a gas mixture containing a certain amount of oxygen and argon.
4 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
INHALATION COMPOSITION FOR INCREASING SPERM CELL VIABILITY AND ACTIVITY | 2024 |
|
RU2835738C1 |
MEANS AND METHOD FOR IMPROVING SPERM QUALITY | 1999 |
|
RU2159122C1 |
METHOD FOR INTEGRATED TREATMENT OF PATHOZOOSPERMIA IN MALES SUFFERING ADRENAL HYPERANDROGENISM | 2012 |
|
RU2510284C1 |
USE OF OXIDISED DEXTRAN FOR TREATING AND PREVENTING INFECTIOUS-INFLAMMATORY DISORDERS OF SPERMATOGENESIS | 2023 |
|
RU2814617C1 |
COMPOSITION FOR IMPROVEMENT OF THE MALE REPRODUCTIVE FUNCTION | 2017 |
|
RU2665636C2 |
METHOD OF EXPERIMENTAL STIMULATION OF SPERMATOGENESIS | 2011 |
|
RU2481132C1 |
METHOD FOR PREDICTING MALE INFERTILITY BASED ON SPERM DNA FRAGMENTATION ANALYSIS | 2023 |
|
RU2804207C1 |
APPLICATION OF MUSK DEER MUSK TINCTURE AND ULTRAVIOLET IRRADIATION OF BLOOD FOR TREATMENT OF SPERMATOGENIC FAILURE IN MEN OF REPRODUCTIVE AGE | 2010 |
|
RU2418581C1 |
METHOD FOR FORECASTING EFFICIENCY OF LOW-INTENSITY LASER THERAPY IN SECRETORY ASTENOZOSPERMIA | 2020 |
|
RU2748895C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING REPRODUCTIVE AND ERECTILE DYSFUNCTIONS IN MEN AND USE THEREOF | 2023 |
|
RU2825382C1 |
Authors
Dates
2025-03-03—Published
2024-12-08—Filed